Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study

被引：0
|
作者：
Manzo-Silberman, S. [1 ]
Cayla, G. [2 ]
Beygui, F. [3 ]
Range, G. [4 ]
Motovska, Z. [5 ]
Vicaut, E. [6 ]
Collet, J. P. [1 ]
Guedeney, P. [1 ]
El Kasty, M. [7 ]
Kerneis, M. [1 ]
Zeitouni, M. [1 ]
Filippi, E. [8 ]
Coste, P. [9 ]
Montalescot, G. [1 ]
Silvain, J. [10 ]
机构：
[1] Sorbonne Univ, Cardiol, Paris, France
[2] Nimes Caremeau Univ Hosp Ctr, Cardiol, Nimes, France
[3] Univ Hosp Caen, Cardiol, Caen, France
[4] Hosp Louis Pasteur Chartres, Cardiol, Chartres, France
[5] Charles Univ Prague, Cardiol, Prague, Czech Republic
[6] St Louis Univ Hosp, Fernand Widal APHP Site, Methodol & Statist, Paris, France
[7] Hosp Sud Francilien, Cardiol, Corbeil Essonnes, France
[8] Vannes Hosp Ctr Bretagne Atlant, Cardiol, Vannes, France
[9] CHU Bordeaux, Cardiol, Bordeaux, France
[10] Sorbonne Univ, Paris, France
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
    Fan, Zhong-Guo
    Zhang, Wen-Ling
    Xu, Bing
    Ji, Jun
    Tian, Nai-Liang
    He, Sheng-Hu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 719 - 730
  • [42] Effects of clopidogrel, prasugrel and ticagrelor on endothelial function and platelet reactivity in patients after percutaneous coronary intervention
    Kokkou, E.
    Tousoulis, D.
    Siasos, G.
    Kioufis, S.
    Oikonomou, E.
    Maniatis, K.
    Mazaris, S.
    Konsola, T.
    Vavuranakis, M.
    Stefanadis, C.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1167 - 1168
  • [43] Clopidogrel, prasugrel, ticagrelor and platelet inhibition in patients after percutaneous coronary intervention: effects on endothelial function
    Oikonomou, E.
    Siasos, G.
    Kokkou, E.
    Oikonomou, E.
    Zaromitidou, M.
    Tsalamandris, S.
    Anastasiou, M.
    Vavuranakis, M.
    Ververeli, C.
    Maniatis, K.
    Zografos, T.
    Antonopoulos, A. S.
    Mourouzis, K.
    Giannaki, A.
    Tousoulis, D.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1232 - 1232
  • [44] Impact of psoriasis on ticagrelor platelet activity versus clopidogrel in patients with chronic coronary syndromes treated via percutaneous coronary intervention
    Januszek, Rafal
    Zabojszcz, Michal
    Cyran-Stemplewska, Sylwia
    Krecisz, Beata
    Bartus, Stanislaw
    Siudak, Zbigniew
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (10):
  • [45] FEWER GASTROINTESTINAL BLEEDS WITH TICAGRELOR WHEN COMPARED TO CLOPIDOGREL OR PRASUGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME FOLLOWING PERCUTANEOUS CORONARY INTERVENTION
    Abraham, Neena S.
    Yang, Eric H.
    Noseworthy, Peter
    Inselman, Jonathan
    Yao, Xiaoxi
    Herrin, Jeph
    Sangaralingham, Lindsey
    Ngufor, Che
    Shah, Nilay
    GASTROENTEROLOGY, 2020, 158 (06) : S58 - S58
  • [46] Prevention of minor myocardial injury after elective percutaneous coronary intervention: comparison of ticagrelor versus clopidogrel
    Goksuluk, Huseyin
    Atmaca, Yusuf
    Uludag, Menekse Gerede
    Kaya, Cansin Tulunay
    Yildirim, Onur
    Akbulut, Muge
    Ozyuncu, Nil
    Ero, Cetin
    ACTA CARDIOLOGICA, 2018, 73 (06) : 584 - 590
  • [47] Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome
    Li, Dandan
    Sun, Yang
    Ye, Xiaoran
    Li, Lanting
    Chen, Yundai
    Wang, Daowen
    ADVANCES IN THERAPY, 2022, 39 (01) : 754 - 766
  • [48] Comparison of Net Clinical Benefit Between Clopidogrel and Ticagrelor Following Percutaneous Coronary Intervention in Patients in China With Acute Coronary Syndrome
    Dandan Li
    Yang Sun
    Xiaoran Ye
    Lanting Li
    Yundai Chen
    Daowen Wang
    Advances in Therapy, 2022, 39 : 754 - 766
  • [49] Ticagrelor Versus Prasugrel in Acute Coronary Syndrome Patients With High On-Clopidogrel Platelet Reactivity Following Percutaneous Coronary Intervention A Pharmacodynamic Study
    Alexopoulos, Dimitrios
    Galati, Anastasia
    Xanthopoulou, Ioanna
    Mavronasiou, Eleni
    Kassimis, George
    Theodoropoulos, Konstantinos C.
    Makris, George
    Damelou, Anastasia
    Tsigkas, Grigorios
    Hahalis, George
    Davlouros, Periklis
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (03) : 193 - 199
  • [50] Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial
    Baber, Usman
    Cao, Davide
    Collier, Timothy
    Sartori, Samantha
    Dangas, George
    Angiolillo, Dominick J.
    Vogel, Birgit
    Kunadian, Vijay
    Briguori, Carlo
    Cohen, David J.
    Dudek, Dariusz
    Gibson, C. Michael
    Gil, Robert
    Huber, Kurt
    Kaul, Upendra
    Kornowski, Ran
    Krucoff, Mitchell W.
    Mehta, Shamir
    Moliterno, David J.
    Ohman, E. Magnus
    Escaned, Javier
    Sardella, Gennaro
    Sharma, Samin K.
    Shlofmitz, Richard
    Weisz, Giora
    Witzenbichler, Bernhard
    Steg, P. Gabriel
    Pocock, Stuart
    Mehran, Roxana
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024,
12345